Haibu Pharmaceutical has been awarded the "Top 50 Pharmaceutical R&D Companies in China" for consecutive years.
Classification:
News
Release time:
2023-09-18
On July 4, 2023, the "2022-2023 Annual Release Conference of the Most Influential List in China's Pharmaceutical Industry and the 15th China Pharmaceutical Industry Development Summit Forum" was grandly held in Harbin, co-hosted by the National Federation of Industry and Commerce Pharmaceutical Industry Chamber, Heilongjiang Provincial Federation of Industry and Commerce, and Heilongjiang Provincial Development and Reform Commission. The conference focused on "Promoting High-Quality Development of the Industry and Revitalizing Northeast Medicine," interpreting policies and discussing hot topics in the pharmaceutical industry from different perspectives. Under the background of the "Healthy China" strategy, it addressed the opportunities and challenges faced by the pharmaceutical industry.
The China Pharmaceutical Industry Development Summit Forum is one of the highest-level and most influential industry events. It aims to guide entrepreneurs in the pharmaceutical industry to operate honestly and legally, using the chamber as a hub to gather advantageous resources for high-quality development in the pharmaceutical sector, promote deep integration of industrial chains, advance technological innovation among member enterprises, and foster specialized, refined, unique, and innovative development. This will continuously enhance innovative thinking and developmental thinking to promote high-quality development across enterprises as a whole.
"The Release Conference of China's Most Influential Pharmaceutical Industry List" has been held for 10 consecutive sessions. Being listed is not only an honor but also a responsibility; companies on the list will serve as role models to continuously promote healthy development in the pharmaceutical industry.
Haibu Pharmaceutical has been awarded "Top 50 in China's Pharmaceutical R&D" for consecutive years. Display of past honor certificates:

Previous Page



